A novel Microchannel Electrode Array: towards
bioelectronics medical interfacing of small peripheral nerves.
Based on this study, in December of last year, SetPoint Medical, a Santa Clarita, Calif.-based clinical-stage biomedical technology company developing an implantable
bioelectronic medicine therapy for chronic inflammatory diseases, was granted Investigational Device Exemption (IDE) approval from the FDA to commence a pilot trial in the U.S.
Hwang, "Fabrication and application of amperometric glucose biosensor based on a novel PtPd bimetallic nanoparticle decorated multi-walled carbon nanotube catalyst," Biosensors and
Bioelectronics, vol.
Li, "Aptamerbiosensor for label-free impedance spectroscopy detection of potassium ion based on DNA G-quadruplex conformation," Biosensors and
Bioelectronics, vol.
Kim et al., "Flexible glucose sensor using CVD-grown graphene-based field effect transistor," Biosensors and
Bioelectronics, vol.
Wang, "Electrochemical sensor for glutathione detection based on mercury ion triggered hybridization chain reaction signal amplification," Biosensors and
Bioelectronics, vol.
A comparison with fluorescence viability monitoring, Biosensors and
Bioelectronics 18(11): 1379-1383.
Bioelectronics is new technology developing miniaturised, implantable devices that could replace pills or injections in the future.
"There are companies working on combining implantable medical devices with Al and
bioelectronics to predict things such as when a patient is due medicine," explained Dr Burke.
8 September 2017 - Kentucky, US-based
bioelectronics medical device company Nexeon MedSystems (OTCQB: NXNN) (NMB) has exercised its option to acquire Belgium-based neurostimulation product developer Nexeon Medsystems Belgium, SPRL, the company said.
"One of the major hurdles in the area of
bioelectronics or implants is that the interface between the electronic device and the tissue or organ is not robust," Tian explains.